Cannabis Weekly Round-Up: Peru on Path for Legal Medical Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Jocelyn Aspa
The Investing News Network had the opportunity to speak with Sean Clark, CEO and co-founder of First Block Capital, about the approval.
Elite Pharmaceuticals filed an abbreviated new drug application with the FDA for a generic version of OxyContin.
GT Biopharma announced that after the acquisition of Georgetown Translational Pharmaceuticals it has changed its stock trading symbol from OXISD to GTBP.
Medovex announced it launched its DenerveX System Device in Spain with distributor Prim SA.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Helius Medical Technologies announced its subsidiary NeuroHabilitation executed an extension to its research and development agreement with the US Army Medical Research and Materiel Command through 2018.
Tetra Bio-Pharma incorporated Dr. Louis-Philippe de Lorimier into their clinical advisory board for the veterinary market.
GT Biopharma announced it made the payment for the license of PainBrake, a non-opioid medication from Accu-Break Pharmaceuticals, which the company plans to develop.
Cipher Pharmaceuticals issued a response to the warning letter from the FDA regarding their pain reliever ConZip.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
By Jocelyn Aspa
Glance Technologies (CSE:GET.CN) has announced that its partially-owned subsidiary, Cannapay Financial, has entered into an agreement to acquire the rights to a package of holistic Ayurveda formulas intended to treat a number of ailments.
As quoted in the press release:
Cannapay has agreed to purchase all of the intellectual property pertaining to
Oncology investing can certainly be intimidating. Here, the Investing News Network looks at companies in the space and other ways to invest.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Thanks to their second quarter financial reports these medical device companies are experiencing growth in their stocks.
Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
Medovex announced it obtained approval from the Australian Therapeutic Goods Administration for their DenerveX System.
Depomed a specialty pharmaceutical focused on pain relief therapies was hit on Monday by a class action lawsuit announcement from law firm Levi & Korsinsky.
